Aims & Scope
Journal of Caffeine and Adenosine Research is the first and only journal dedicated to publishing the rapidly advancing field of caffeine and adenosine signaling research. Multidisciplinary in scope, the Journal addresses the need for an authoritative source on caffeine and adenosine’s role in biological processes. The Journal encompasses all aspects of adenosine, from the molecular structure and function of receptors, enzymes and transporters, to the biochemistry, physiology and pharmacology of adenosine signaling; from the physiological role of adenosine in neuromodulation, inflammation and innate immunity, to its pathophysiological role in neuropsychiatric disorders and cancer. In addition, the Journal holds special interest in caffeine, the adenosine receptor antagonist that constitutes the most consumed psychoactive drug in the world. The Journal publishes a broad range of human and animal studies including basic and translational research on adenosine; and clinical, behavioral, pharmacological research on caffeine.
Journal of Caffeine and Adenosine Research coverage includes:
- Molecular biology
- Biochemistry and pharmacology
- Medicinal chemistry
- Neurophysiology, epilepsy and movement disorders
- Cognition and neurodegenerative disorders
- Psychiatric disorders
- Sleep and sleep disorders
- Cancer and Inflammation
- Cardiovascular function and disease
- Preclinical and clinical research
Journal of Caffeine and Adenosine Research is under the editorial leadership of Editor-in-Chief Sergi Ferré, MD, PhD, National Institute on Drug Abuse, and other leading investigators. View the entire editorial board.
Audience: Biomedical researchers, neurologists, psychiatrists, cardiologists, oncologists, immunologists, pharmacologists, exercise physiologists, sports medicine specialists, pharmacologists, food scientists, behavioral and social science researchers, epidemiologists, and addiction medicine specialists, among others